77.18
price up icon3.44%   2.57
 
loading
Precedente Chiudi:
$74.61
Aprire:
$74.91
Volume 24 ore:
653.32K
Relative Volume:
1.10
Capitalizzazione di mercato:
$5.12B
Reddito:
-
Utile/perdita netta:
$-224.29M
Rapporto P/E:
-19.79
EPS:
-3.9
Flusso di cassa netto:
$-185.06M
1 W Prestazione:
+5.02%
1M Prestazione:
-0.36%
6M Prestazione:
-18.13%
1 anno Prestazione:
+17.62%
Intervallo 1D:
Value
$72.69
$77.50
Intervallo di 1 settimana:
Value
$70.25
$77.50
Portata 52W:
Value
$55.53
$113.51

Nuvalent Inc Stock (NUVL) Company Profile

Name
Nome
Nuvalent Inc
Name
Telefono
508-446-2272
Name
Indirizzo
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
Name
Dipendente
162
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
NUVL's Discussions on Twitter

Confronta NUVL con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NUVL
Nuvalent Inc
77.18 5.19B 0 -224.29M -185.06M -3.90
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.93 25.76B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.43 114.53B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.415 40.54M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
84.10 6.44B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.81 65.13B 14.09B 4.50B 2.96B 39.28

Nuvalent Inc Stock (NUVL) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-14 Aggiornamento UBS Neutral → Buy
2024-12-30 Iniziato H.C. Wainwright Buy
2024-10-24 Iniziato UBS Neutral
2024-08-29 Iniziato Barclays Overweight
2024-04-17 Iniziato Jefferies Buy
2024-04-01 Aggiornamento Leerink Partners Market Perform → Outperform
2024-02-28 Ripresa Guggenheim Buy
2024-02-23 Iniziato Robert W. Baird Outperform
2023-09-27 Iniziato Stifel Buy
2023-08-08 Iniziato SVB Securities Market Perform
2023-07-24 Iniziato Guggenheim Buy
2023-01-18 Iniziato Wedbush Outperform
2022-06-24 Iniziato BMO Capital Markets Outperform
Mostra tutto

Nuvalent Inc Borsa (NUVL) Ultime notizie

pulisher
May 30, 2025

Nuvalent, Inc. Reports Q1 2025 Financial Results - TipRanks

May 30, 2025
pulisher
May 30, 2025

Nuveen Asset Management LLC Has $6.62 Million Stock Position in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

May 30, 2025
pulisher
May 29, 2025

Nuvalent to Present Preliminary Data from ALKOVE-1 Phase 1/2 Clinical Trial of NVL-655 at 35th AACR-NCI-EORTC Symposium - The Globe and Mail

May 29, 2025
pulisher
May 29, 2025

Nuvalent (NUVL) Stock on the Rise: Decoding the 4.7% Surge and Price Potential - Daily Chhattisgarh News

May 29, 2025
pulisher
May 22, 2025

Nuvalent’s SWOT analysis: cancer drug developer’s stock faces pivotal year By Investing.com - Investing.com Nigeria

May 22, 2025
pulisher
May 22, 2025

Nuvalent’s SWOT analysis: cancer drug developer’s stock faces pivotal year - Investing.com Australia

May 22, 2025
pulisher
May 22, 2025

Deutsche Bank AG Has $2.79 Million Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

May 22, 2025
pulisher
May 21, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World

May 21, 2025
pulisher
May 20, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Shares Acquired by Bank of America Corp DE - Defense World

May 20, 2025
pulisher
May 20, 2025

BNP Paribas Financial Markets Acquires Shares of 17,366 Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

May 20, 2025
pulisher
May 11, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Shares Sold by Dimensional Fund Advisors LP - Defense World

May 11, 2025
pulisher
May 09, 2025

A Bullish 2025 Outlook For Nuvalent Inc (NASDAQ: NUVL) Shares - Stocksregister

May 09, 2025
pulisher
May 09, 2025

Decoding Nuvalent Inc (NUVL): A Strategic SWOT Insight - GuruFocus

May 09, 2025
pulisher
May 08, 2025

Nuvalent (NUVL) Targets Key Milestones with Solid Financial Backing | NUVL Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Nuvalent Outlines Recent Pipeline and Business Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2025 Financial Results - PR Newswire

May 08, 2025
pulisher
May 07, 2025

Financial Health Check: Examining Nuvalent Inc (NUVL)’s Key Ratios - DWinneX

May 07, 2025
pulisher
May 05, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Stock Holdings Lowered by Envestnet Asset Management Inc. - Defense World

May 05, 2025
pulisher
May 03, 2025

When the Price of (NUVL) Talks, People Listen - news.stocktradersdaily.com

May 03, 2025
pulisher
May 02, 2025

Nuvalent Inc (NUVL) looking to reclaim success with recent performance - Sete News

May 02, 2025
pulisher
May 01, 2025

Nuvalent Highlights Corporate and Pipeline Achievements and Reports Third Quarter 2023 Financial Results - Seeking Alpha

May 01, 2025
pulisher
Apr 29, 2025

Nuvalent reveals preclinical data on cancer drug zidesamtinib - Investing.com

Apr 29, 2025
pulisher
Apr 29, 2025

Nuvalent Announces Publication in Molecular Cancer Therapeutics - GuruFocus

Apr 29, 2025
pulisher
Apr 29, 2025

Nuvalent Announces Publication in Molecular Cancer Therapeutics Reinforcing Rational Molecular Design of Zidesamtinib as a Novel ROS1-Selective Inhibitor - PR Newswire

Apr 29, 2025
pulisher
Apr 29, 2025

Indo-Asian News Service - Indo-Asian News Service (IANS)

Apr 29, 2025
pulisher
Apr 27, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Position Boosted by Wells Fargo & Company MN - Defense World

Apr 27, 2025
pulisher
Apr 26, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World

Apr 26, 2025
pulisher
Apr 23, 2025

Nuvalent, Inc. (NUVL): Among Takeover Rumors Hedge Funds Are Buying - Yahoo Finance

Apr 23, 2025
pulisher
Apr 23, 2025

Nuvalent to Present Trial in Progress Posters for the ALKAZAR Trial of Neladalkib and HEROEX-1 Trial of NVL-330 at the 2025 American Society of Clinical Oncology Annual Meeting - ADVFN

Apr 23, 2025
pulisher
Apr 23, 2025

Is Nuvalent, Inc. (NUVL) Among the Best Guru Stocks to Buy According to Wall Street Analysts? - Insider Monkey

Apr 23, 2025
pulisher
Apr 22, 2025

Nuvalent describes new ROS and ALK tyrosine kinase receptor inhibitors - BioWorld MedTech

Apr 22, 2025
pulisher
Apr 21, 2025

UBS gives a Buy recommendation for Nuvalent Inc (NUVL) - knoxdaily.com

Apr 21, 2025
pulisher
Apr 18, 2025

JPMorgan Chase & Co. Acquires 47,818 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Apr 18, 2025
pulisher
Apr 18, 2025

Trend Tracker for (NUVL) - news.stocktradersdaily.com

Apr 18, 2025
pulisher
Apr 17, 2025

Nuvalent Board Member Resigns, Joins Advisory Board - TipRanks

Apr 17, 2025
pulisher
Apr 16, 2025

Alliancebernstein L.P. Purchases 500 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Apr 16, 2025
pulisher
Apr 11, 2025

Commonwealth Equity Services LLC Raises Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

Sei Investments Co. Reduces Stock Position in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Apr 10, 2025
pulisher
Apr 09, 2025

Nuvalent (NUVL) Gets a Buy from Barclays - The Globe and Mail

Apr 09, 2025
pulisher
Apr 08, 2025

Nuvalent: Cannot Make Sense Of The Valuation - Seeking Alpha

Apr 08, 2025
pulisher
Apr 07, 2025

Nuvalent stock touches 52-week low at $61.75 amid market shifts By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

Nuvalent stock touches 52-week low at $61.75 amid market shifts - Investing.com Australia

Apr 07, 2025
pulisher
Apr 07, 2025

Norges Bank Invests $24.95 Million in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Apr 07, 2025
pulisher
Apr 03, 2025

KLP Kapitalforvaltning AS Buys New Shares in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

What to Expect at AACR 2025: Nuvalent to present Data on Neladalkib and Zidesamtinib - Onco'Zine

Apr 02, 2025
pulisher
Apr 02, 2025

Commit To Purchase Nuvalent At $55, Earn 11.9% Annualized Using Options - Nasdaq

Apr 02, 2025
pulisher
Apr 01, 2025

(NUVL) On The My Stocks Page - news.stocktradersdaily.com

Apr 01, 2025
pulisher
Apr 01, 2025

Is Nuvalent (NUVL) the Best Debt Free Mid Cap Stock to Buy Now? - Yahoo

Apr 01, 2025
pulisher
Apr 01, 2025

Nuvalent to Participate in the Stifel 2025 Virtual Targeted Oncology Forum - Quantisnow

Apr 01, 2025
pulisher
Apr 01, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Apr 01, 2025
pulisher
Mar 30, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Stake Cut by Virtu Financial LLC - MarketBeat

Mar 30, 2025
pulisher
Mar 30, 2025

Teacher Retirement System of Texas Boosts Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 30, 2025

Nuvalent Inc Azioni (NUVL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$1.15
price up icon 6.48%
$31.19
price up icon 3.48%
$584.61
price up icon 1.98%
$306.09
price up icon 0.50%
$4.5994
price up icon 2.21%
$490.81
price up icon 0.11%
Capitalizzazione:     |  Volume (24 ore):